Nice to see some progression in the distribution agreement in...

Nice to see some progression in the distribution agreement in the US as well as an additional placement.


Also good to see that VRE is progressing. I believe from an old presentation that the target addressable market for LBT's APAS was 400 European labs, so there's a potential of 240 labs utilising the Urine module which would be nice.

There was also a nice note regarding how there's discussions with the UK HALO lab to procure one or more instruments. As well as a EU based sales executive demonstrating full efficiencies of the APAS machine in Ravensburg which is 'an important step' for more Labs within the limbach group to adopt the APAS.

Let's hope there's some action this quarter with realising some of this. that'll put in a little bit of much needed up side, Surely BB and the board realise this is a critical quarter and need to kick some goals